NEKTAR THERAPEUTICS

NKTR
Real-time Estimate Quote. Real-time Estimate  - 09/24 02:14:36 pm
18.26USD -3.44%
Prev.18.9100
Open18.8500
High18.8500
Low18.1650
Volume509 561
Latest news
08/12
08/07
08/06
08/06
Chart NEKTAR THERAPEUTICS
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralNeutral
Resistance20,324,826,9
Spread/Res.-9,6%-26%-32%
Spread/Supp.-0,33%9,0%13%
Support18,416,916,3
Financials
Sales 2020 147 M - -
Net income 2020 -505 M - -
Net cash 2020 170 M - -
P/E ratio 2020 -6,67x
Yield 2020 -
Capitalization 3 383 M 3 383 M -
EV / Sales 2020 21,8x
EV / Sales 2021 21,2x
Nbr of Employees 723
Free-Float 99,3%
Company
Nektar Therapeutics specializes in the research and development of drugs for the treatment of cancer, autoimmune diseases and chronic pain. Net sales break down by source of income as follows:
- revenues from licensing and collaboration agreements (91.9%);
- product sales (4.6%);
- royalties...

>> Read more
Sector :
Biotechnology & Medical Research - NEC
Calendar :
2020-10-08 Presentation
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 31,23 $
Last Close Price 18,91 $
Spread / Highest target 323%
Spread / Average Target 65,2%
Spread / Lowest Target -10,1%